🇺🇸 FDA
Patent

US 10988450

3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

granted A61PA61P1/04A61P17/06

Quick answer

US patent 10988450 (3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors) held by Valo Early Discovery, Inc. expires Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Valo Early Discovery, Inc.
Grant date
Tue Apr 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61P, A61P1/04, A61P17/06, A61P19/02, A61P19/04